WASHINGTON — Sluggish response and questionable decisions by the Food and Drug Administration exacerbated the nation's infant formula shortage, agency officials told lawmakers at a congressional hearing on Wednesday.
"You're right to be concerned, and the public should be concerned," said FDA Commissioner Robert Califf. The agency's response "was too slow and there were decisions that were suboptimal along the way."
Lawmakers grilled FDA officials during an hours-long hearing with the House Committee on Energy and Commerce, questioning what led to the formula shortage that is plaguing parents of infants across the nation.
